NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹NaN
0.00%
NAV as on Datlid , 12:NaN AM
very high risk
sector specific pharma
equity
NAV as on Datlid , 12:NaN AM
very high risk
sector specific pharma
equity
0.00%p.a.
Last 1Y
0.00%p.a.
Last 3Y
0.00%p.a.
Last 5Y
0.00%p.a.
Since Inception
NRIs can achieve long-term capital appreciation by investing in the Bandhan Healthcare Fund - Plan - Growth scheme from Bandhan AMC Limited. It is a Sector Specific - Pharma mutual fund scheme that predominantly invests in Sector Specific - Pharma stocks of companies. Launched on Nov 2025, Bandhan Healthcare Fund - Plan - Growth is Sector Specific - Pharma fund of its category with 0 fund under management as on Jan 1970. The expense ratio of this fund is less than that of most other Fund category Sector Specific - Pharma funds.
The scheme seeks to generate long-term capital appreciation by investing predominantly in equity and equity-related instruments of companies engaged in Healthcare, Pharma and Allied sectors.
View Scheme Document
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
If all details are correct, your KYC will be approved within 7 to 8 business days.
Funds
3Y Return

moderate risk | debt
0.0%

moderate risk | debt
0.0%

moderate risk | debt
0.0%